9 completed. 9 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 9 | Completed 9 |
Follow Rabies: new trials by email Literature Review of Rabies trials Research Report on Rabies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Purified Verocell Rabies Vaccine PVRV Administered Intramuscularly and Intradermally PVRV - Rabies | Phase 4 | Completed | University of Peshawar | 100 | 2020-07-01 | 2024-05-29 |
| Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally RABIVAX-S - Rabies | Phase 4 | Completed | Vietnam Military Medical University | 220 | 2020-06-13 | 2023-07-20 |
| Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine 5 doses program - Rabies, Antibody | Phase 4 | Completed | Changchun Zhuoyi Biological Co., Ltd | 149 | 2019-11-11 | 2022-09-21 |
| Non-specific Effects of Rabies Vaccine Rabivax-S, Sterile Water Injection - Influenza-like Illness, Upper Respiratory Disease | Phase 4 | Completed | Ross University School of Veterinary Medicine | 546 | 2018-08-29 | 2021-08-13 |
| Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. Chloroquine, Atovaquone and Proguanil, Doxycycline - Rabies | Phase 4 | Completed | State University of New York - Upstate Medical University | 103 | 2016-11-11 | 2021-05-13 |
| Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis Rabies vaccine, Placebo - Rabies | Phase 4 | Completed | State University of New York - Upstate Medical University | 60 | 2015-03-24 | 2022-06-13 |
| Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules Purified Chick Embryo Cell Inactivated Rabies Vaccine - Rabies | Phase 4 | Completed | Novartis Vaccines | 250 | 2011-07-01 | 2014-05-05 |
| Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG SPEEDA and TRCS SPEEDA - Rabies | Phase 4 | Completed | Queen Saovabha Memorial Institute | 210 | 2010-06-01 | 2018-04-06 |
| Immunogenicity and Safety of Verorab™ in Indian Population Purified Verocell Rabies Vaccine - Rabies | Phase 4 | Completed | Sanofi Pasteur, a Sanofi Company | 405 | 2004-12-01 | 2014-01-14 |
Diarrhea (1) · Fever (1) · Respiration Disorders (1)
Infections (9) · Mononegavirales Infections (9) · RNA Virus Infections (9) · Rhabdoviridae Infections (9) · Virus Diseases (9) · Body Temperature Changes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Rabies Vaccines (2) · Albumins (1) · Chloroquine (1) · Doxycycline (1) · atovaquone, proguanil drug combination (1) · chloroquine diphosphate (1)
State University of New York - Upstate Medical University (2) · Changchun Zhuoyi Biological Co., Ltd (1) · Novartis Vaccines (1) · Queen Saovabha Memorial Institute (1) · Ross University School of Veterinary Medicine (1) · Sanofi Pasteur, a Sanofi Company (1) · University of Peshawar (1) · Vietnam Military Medical University (1)
India (2) · United States (2) · China (1) · Pakistan (1) · Saint Kitts and Nevis (1) · Thailand (1) · Vietnam (1)
Darryn Knobel, PhD (1) · Li Miao, Dr (1) · Mark Polhemus, MD (1) · Mohammad Ismail, PhD (1) · Pham N Hung, As. Prof. (1) · Terapong Tantawichien, MD.,Prof (1) · Timothy Endy, MD (1) · Waqar Ali, MPhil (1)
PMID 25692792, PMID 31743394, PMID 31802120, PMID 32546199, PMID 34127294, PMID 39927222